(2) subsection (g)(4)(A) of that section shall be 
applied and administered by inserting ‘‘and the At-
torney General’’ after ‘‘Secretary of Defense’’; and 
(3) subsections (h)(2)(A) and (i)(1)(A) of that 
section shall be applied and administered by sub-
stituting ‘‘level V of the Executive Schedule under 
section 5316’’ for ‘‘level IV of the Executive Sched-
ule under section 5315’’. 
(e) TREATMENT OF INFORMATION RELATING TO NA-
TIONAL SECURITY.— 
(1) RESPONSIBILITY
OF
DIRECTOR
OF
NA-
TIONAL INTELLIGENCE.—The Director of National 
Intelligence shall assume responsibility for the han-
dling and disposition of any information related to 
the national security of the United States that is re-
ceived, considered, or used by the Commission under 
this section. 
(2) INFORMATION PROVIDED BY CONGRESS.— 
Any information related to the national security of 
the United States that is provided to the Commis-
sion by the appropriate congressional committees 
and leadership may not be further provided or re-
leased without the approval of the chairperson of the 
committee, or the Member of Congress, as the case 
VerDate Sep 11 2014 
04:13 Apr 19, 2019
Jkt 089200
PO 00000
Frm 00031
Fmt 6652
Sfmt 6201
E:\BILLS\H2226.IH
H2226
kjohnson on DSK79L0C42 with BILLS
may be, that provided the information to the Com-
mission. 
(3) ACCESS AFTER TERMINATION OF COMMIS-
SION.—Notwithstanding any other provision of law, 
after the termination of the Commission under sub-
section (h), only the members and designated staff 
of the appropriate congressional committees and 
leadership, the Director of National Intelligence (and 
the designees of the Director), and such other offi-
cials of the executive branch as the President may 
designate shall have access to information related to 
the national security of the United States that is re-
ceived, considered, or used by the Commission. 
(f) REPORTS.—The Commission shall submit to the 
appropriate congressional committees and leadership— 
(1) not later than 270 days after the date of 
the enactment of this Act, an initial report on the 
activities and recommendations of the Commission 
under this section; and 
(2) not later than 270 days after the submis-
sion of the initial report under paragraph (1), a final 
report on the activities and recommendations of the 
Commission under this section. 
(g) LIMITATION ON FUNDING.—Of amounts made 
available under sections 302, 303, and 304 to carry out 
VerDate Sep 11 2014 
04:13 Apr 19, 2019
Jkt 089200
PO 00000
Frm 00032
Fmt 6652
Sfmt 6201
E:\BILLS\H2226.IH
H2226
kjohnson on DSK79L0C42 with BILLS
this Act, not more than $5,000,000 shall be available to 
the Commission in any of fiscal years 2020 through 2025. 
(h) TERMINATION.— 
(1) IN GENERAL.—The Commission, and all the 
authorities of this section, shall terminate at the end 
of the 120-day period beginning on the date on 
which the final report required by subsection (f)(2) 
is submitted to the appropriate congressional com-
mittees and leadership. 
(2) WINDING UP OF AFFAIRS.—The Commis-
sion may use the 120-day period described in para-
graph (1) for the purposes of concluding its activi-
ties, including providing testimony to Congress con-
cerning the final report required by subsection (f)(2) 
and disseminating the report. 
TITLE III—OTHER MATTERS 
SEC. 301. DIRECTOR OF NATIONAL INTELLIGENCE PRO-
GRAM 
ON 
USE 
OF 
INTELLIGENCE 
RE-
SOURCES IN EFFORTS TO SANCTION FOR-
EIGN OPIOID TRAFFICKERS. 
(a) PROGRAM REQUIRED.— 
(1) IN GENERAL.—The Director of National In-
telligence shall, with the concurrence of the Director 
of the Office of National Drug Control Policy, carry 
out a program to allocate and enhance use of re-
VerDate Sep 11 2014 
04:13 Apr 19, 2019
Jkt 089200
PO 00000
Frm 00033
Fmt 6652
Sfmt 6201
E:\BILLS\H2226.IH
H2226
kjohnson on DSK79L0C42 with BILLS
sources of the intelligence community, including in-
telligence collection and analysis, to assist the Sec-
retary of the Treasury and the Administrator of the 
Drug Enforcement Administration in efforts to iden-
tify and impose sanctions with respect to foreign 
opioid traffickers under title I. 
(2) FOCUS ON ILLICIT FINANCE.—To the ex-
tent practicable, efforts described in paragraph (1) 
shall— 
(A) take into account specific illicit finance 
risks related to narcotics trafficking; and 
(B) be developed in consultation with the 
Undersecretary of the Treasury for Terrorism 
and Financial Crimes, appropriate officials of 
the Office of Intelligence and Analysis of the 
Department of the Treasury, the Director of 
the Financial Crimes Enforcement Network, 
and appropriate Federal law enforcement agen-
cies. 
(b) REVIEW OF COUNTERNARCOTICS EFFORTS OF 
THE INTELLIGENCE COMMUNITY.—The Director of Na-
tional Intelligence shall, in coordination with the Director 
of the Office of National Drug Control Policy, carry out 
a comprehensive review of the current intelligence collec-
tion priorities of the intelligence community for counter-
VerDate Sep 11 2014 
04:13 Apr 19, 2019
Jkt 089200
PO 00000
Frm 00034
Fmt 6652
Sfmt 6201
E:\BILLS\H2226.IH
H2226
kjohnson on DSK79L0C42 with BILLS
narcotics purposes in order to identify whether such prior-
ities are appropriate and sufficient in light of the number 
of lives lost in the United States each year due to use 
of illegal drugs. 
(c) REPORTS.— 
(1) QUARTERLY REPORTS ON PROGRAM.—Not 
later than 90 days after the date of the enactment 
of this Act, and every 90 days thereafter, the Direc-
tor of National Intelligence and the Director of the 
Office of National Drug Control Policy shall jointly 
submit to the appropriate congressional committees 
and leadership a report on the status and accom-
plishments of the program required by subsection 
(a) during the 90-day period ending on the date of 
the report. The first report under this paragraph 
shall also include a description of the amount of 
funds devoted by the intelligence community to the 
efforts described in subsection (a) during each of fis-
cal years 2017 and 2018. 
(2) REPORT ON REVIEW.—Not later than 120 
days after the date of the enactment of this Act, the 
Director of National Intelligence and the Director of 
the Office of National Drug Control Policy shall 
jointly submit to the appropriate congressional com-
mittees and leadership a comprehensive description 
VerDate Sep 11 2014 
04:13 Apr 19, 2019
Jkt 089200
PO 00000
Frm 00035
Fmt 6652
Sfmt 6201
E:\BILLS\H2226.IH
H2226
kjohnson on DSK79L0C42 with BILLS